Background. A recent collaborative meta-analysis by Kidney Disease: Improving Global Outcomes reported that an estimated glomerular filtration rate (eGFR) <60 mL/min/ 1.73m 2 and an albumin-to-creatinine ratio of !10 mg/g were independent predictors for mortality in the general population. However, selection bias, heterogeneity of the cohorts and measurement issues could be limitations. Methods. We analyzed the relationship of eGFR and proteinuria with mortality in the Korean general population, represented by 112 115 participants, aged !20 years, who had a voluntary health check-up with homogenous calibration of creatinine measurement from 2003 to 2009. Proteinuria (trace or more) was determined by urine dipstick. Results. eGFR and proteinuria were independently associated with all-cause mortality (ACM) and cardiovascular mortality (CVM), and progressive increases in risks for mortality were noted according to eGFR level and the presence of proteinuria. Compared with eGFR 90-105 mL/min/ 1.73m 2 , hazard ratio (HRs) for ACM were 1.60 [95% confidence interval (CI) 1.12-2.30] for eGFR 60-74 mL/min/ 1.73m 2 and 3.54 (2.20-5.68) for eGFR <60 mL/min/ 1.73m 2 in participants with no proteinuria. In participants with proteinuria, HRs for ACM were 2.10 (1.41-3.12) for eGFR 75-89 mL/min/1.73m 2 , 2.30 (1.50-3.53) for eGFR 60-74 mL/min/1.73m 2 and 3.77 (2.15-6.38) for eGFR <60 mL/min/1.73m 2 . Similar findings were observed for CVM. Conclusions. eGFR <75 mL/min/1.73m 2 and urine dipstick trace or more were independent risk factors of ACM and CVM. The risks of adverse outcomes are greater in the general population with mild renal impairment or mild proteinuria.
Introduction
Chronic kidney disease (CKD) is associated with mortality and cardio-renal outcomes. The 2002 Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines defined CKD as the presence of kidney damage or reduced glomerular filtration rate (GFR <60 mL/min/1.73m 2 ) for !3 months and assigned five stages based on the GFR level [1, 2] . However, there has been increasing recognition of the limitation of the current CKD definition and stages; for example, the use of albuminuria to define the stages to CKD, specific GFR threshold value according to age or sex and emphasizing the clinical diagnosis in addition to GFR and albuminuria [3] [4] [5] [6] [7] . In 2009, Kidney Disease: Improving Global Outcomes (KDIGO) initiated a collaborative metaanalysis, including 45 general population cohorts, a high-risk population and a CKD population [8] [9] [10] [11] [12] . They examined the relative risks of mortality according to categories of estimated GFR (eGFR) compared to the reference group KDIGO [eGFR 90-104 mL/min/1.73m 2 and albumin-to-creatinine ratio (ACR) <10 mg/g] and reported that eGFR <60 mL/ min/1.73m 2 and an ACR of !10 mg/g were independent predictors for mortality in the general population [9] . However, this analysis included many subjects who had an outpatient serum creatinine and urinary protein as part of routine care and included ethnically diverse cohorts with a heterogeneous prevalence of comorbidities. In addition, the measurements of eGFR were not uniformly calibrated with standardized creatinine [8, 9] .
We analyzed the independent and combined relationship of eGFR and proteinuria with all-cause mortality (ACM) and cardiovascular mortality (CVM) by eGFR categories used in a KDIGO controversies conference report, in the Korean general population who had a voluntary routine health check-up at tertiary hospitals, with homogenous calibration of creatinine measurement.
Materials and methods

Participants
We included 112 115 adult participants, aged !20 years, who had a voluntary routine health check-up between 2003 and 2009 at three tertiary hospitals: Seoul National University Hospital, Seoul National University Bundang Hospital and Seoul National University Healthcare System Gangnam Center. We analyzed the data acquired during the first visit if a subject had multiple examinations. The subjects answered questions about smoking and drinking habits, medical history of renal disease, diabetes mellitus (DM), hypertension (HTN), angina pectoris, acute myocardial infarction (AMI) and self-medication prior to the examination.
Measurements and definitions
The subjects arrived at the hospitals after an overnight fast for at least 12 h, completed the questionnaires and underwent blood and urine tests. A spot urine sample was collected in the daytime. Serum creatinine values were measured by the alkaline picrate Jaffe kinetic method using a Hitachi 7600 analyzer (Toshiba, 200FR, Tokyo, Japan) in three hospitals. Serum creatinine levels were calibrated to an assay traceable to isotope dilution mass spectrometry (IDMS) (Roche diagnostics) [13] . The eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) study equation [13] and the re-expressed MDRD equation with a Korean coefficient of 0.9901 [14] . Proteinuria was determined by urine dipstick test and defined as being protein trace or more. An automated urine analyzer CLINITEK ATLAS was used in the three hospitals. HTN was defined as systolic blood pressure (SBP) of !140 mmHg, diastolic blood pressure (DBP) of !90 mmHg, a self-reported history of HTN or use of anti-HTN medications. DM was defined as a fasting glucose of !126 mg/dL, a self-reported history of DM or use of anti-diabetic agents. A history of coronary artery disease was defined as a self-reported history of angina or AMI. Body mass index (BMI) was calculated based on weight and height [weight (kg)/ height (m 2 )]. The components of metabolic syndrome were defined by the National Cholesterol Education Program ATP III [15] .
Outcomes
We joined the mortality data from Statistics Korea to our data set using each individual's unique identifier [16] . Mortality data were obtained until December 2009. The cause of death was specified using ICD-10 code. CVM was defined as codes I20, 21, 25, 26, 42, 46-51, 60-64, 67, 69-71, K55, R57, 96.
Statistical analyses
All analyses were performed using SPSS (SPSS version 15.0; Chicago, IL). Data were presented as the mean AE SD for continuous variables and as proportions for categorical variables. Differences in continuous variables were analyzed by one-way analysis of variance tests and by chi-square tests in categorical variables. We compared the cumulative incidence of ACM and CVM between participants, categorized into five groups according to baseline eGFR level, by log-rank test. Cox's hazard proportional analysis was used to estimate the hazard ratios (HRs) for ACM and CVM. These analyses were adjusted for age, SBP, DBP, BMI, DM, hepatitis B virus s antigenemia (HBsAg), anti-hepatitis C virus antibody (anti-HCV antibody), alanine transferase (ALT), aspartate transferase (AST), fasting glucose, uric acid, total cholesterol, high-density lipoprotein cholesterol (HDL cholesterol) and albumin. The reference group of eGFR 90-104 mL/ min/1.73m 2 (eGFR Group 2) and negative results for urine protein by dipstick were chosen because they were considered to represent the participants with the lowest risk. P-values were reported with 0.05 taken as the level of statistical significance.
Results
Characteristics of participants at the first examination
Of the 112 115 study participants, the mean age was 48.9 years, 53.7% of participants were male, 21.8% had HTN, 7.0% had DM and 14.4% had metabolic syndrome. The participants were categorized according to eGFR: 14.1% (!105 mL/min/1.73m
2 ), 22.3% (90-104 mL/min/1.73m 2 ), 38.4% (75-89 mL/min/1.73m
2 ), 22.1% (60-74 mL/min/ 1.73m
2 ) and 3.1% (<60 mL/min/1.73m 2 ) were eGFR Groups 1-5, respectively (Table 1) . Gender, age, BMI, SBP, DBP, DM, HTN, components of metabolic syndrome, HBsAg, anti-HCV antibody, hemoglobin, calcium, phosphorus, uric acid, albumin, bilirubin, alkaline phosphatase, ALT, AST, gamma glutamyl transferase, cholesterol, HDL cholesterol, glucose, HbA1c, blood urea nitrogen, creatinine, GFR and urine protein were analyzed according to eGFR groups (Table 1) .
Incidence of ACM according to eGFR group and proteinuria level
We assessed the interaction between proteinuria and eGFR to determine ACM by logistic regression, and no significant interaction was found between proteinuria and eGFR (P ¼ 0.202).
Of the 482 deaths (0.4%) observed at 49 months median follow-up, the leading cause of death was neoplasm (54.4%), followed by cardiovascular disease (14.3%) ( Table 2 ).
The ACM incidence of all participants was continuously increased with advancing eGFR group (0.25, 0.30, 0.42, 0.53 and 1.62%, for eGFR Groups 1-5, respectively; P < 0.001) ( Figure 1A ), and according to the proteinuria level by dipstick test (urine dipstick negative, 0.36%; trace or 11, 0.63%; !21, 1.46%; P < 0.001) ( Figure 1B ). Similar findings were seen in Figure 2 regarding the cumulative ACM incidence in all participants according to eGFR. Women showed a constantly lower ACM incidence compared to men according to eGFR and proteinuria level. eGFR Groups 2 and 1 showed the lowest ACM incidence for men and women, respectively.
Incidence of CVM according to eGFR group and proteinuria level
Among the 69 deaths (0.1%), CVM incidence was much lower in women (12.9%) than in men. CVM incidence continuously increased with advancing eGFR group (0.01, 0.02, 0.03, 0.12 and 0.54%, for eGFR Groups 1-5, respectively; P < 0.001) ( Figure 3A) , and according to the proteinuria level by dipstick test (urine dipstick negative, 0.05%; trace or 11, 0.09%; !21, 0.58%; P < 0.001) ( Figure 3B ). Survival curves showed that the cumulative CVM incidence had no difference among eGFR Groups 1, 2 and 3, and a higher CVM incidence was observed in eGFR Groups 4 and 5 ( Figure 4 ).
ACM and CVM according to eGFR and dipstick urine analysis for proteinuria
Adjusted risks of ACM were constant between eGFR 75-89 and !105 mL/min/1.73m 2 and increased in participants with eGFR <75 mL/min/1.73m 2 . In participants with no proteinuria, HRs for ACM were 1.60 [95% confidence interval (CI) 1.12-2.30] for eGFR Group 4 and 3.54 (95% CI 2.20-5.68) for eGFR Group 5 compared with the reference group (eGFR 90-104 mL/min/1.73m 2 and urine dipstick negative). The adjusted HRs of ACM were greater with proteinuria categories. In participants with proteinuria, HRs for ACM were 2.10 (95% CI 1.41-3.12), 2.30 (95% CI 1.50-3.53) and 3.77 (95% CI 2.15-6.38) for eGFR Groups 3, 4 and 5 (Table 3) .
Similar findings were observed for CVM. Adjusted risks of CVM were increased in participants with eGFR <75 mL/min/1.73m 2 . In participants with no proteinuria, HRs for CVM were 3.19 (95% CI 1.05-9.67) and 10.87 (95% CI 3.16-37.41) for eGFR Groups 4 and 5, respectively, compared with the reference group. In participants with proteinuria, HRs for CVM were 7.04 (95% CI 2.20-22.57) and 14.60 (95% CI 4.06-52.53) for eGFR Groups 4 and 5, respectively (Table 3) . 
ACM according to eGFR and dipstick urine analysis for proteinuria in each gender
We reanalyzed ACM according to eGFR and proteinuria in each gender. In both men and women, the relation between eGFR <75 mL/min/1.73m 2 and ACM was statistically significant.
In men, the HR for ACM was 1.55 (95% CI 1.02-2.36) and 3.57 (95% CI 2.08-6.11) for eGFR Groups 4 and 5, respectively, in participants with no proteinuria. In participants with proteinuria, risks of ACM were increased in eGFR <90 mL/min/1.73m 2 . HR for ACM was 1.93 (95% CI 1.22-3.06), 2.05 (95% CI 1.25-3.37) and 3.67 (95% CI 2.02-6.67) for eGFR Groups 3, 4 and 5, respectively, in men (Table 4) .
In women, eGFR <60 mL/min/1.73m 2 was significantly associated with ACM in the no proteinuria group (HR 3.29; 95% CI 1.14-9.46). However, eGFR <90 mL/min/1.73m 2 was associated with ACM in the proteinuria group: HR was 2.85 (95% CI 1.31-6.20), 3.86 (95% CI 1.64-9.07) and 3.20 (95% CI 0.70-14.56) for eGFR Groups 3, 4 and 5, respectively. Contrary to men, however, lower HR was seen in eGFR !105 mL/min/1.73m 2 compared to eGFR 90-104 mL/min/1.73m 2 (HR 0.72; 95% CI 0.36-1.44) ( Table 4) .
Discussion
CKD has become a public health problem around the world with adverse outcomes and high cost. The incidence and prevalence of CKD have been increasing, particularly the early stages of CKD [17] . KDOQI proposed a conceptual model of CKD suggesting that a decrease in GFR results from antecedent kidney damage and that kidney failure is preceded by a decrease in GFR [1, 18] . Although CKD is a heterogeneous condition with various causes, clinical characteristics and rate of progression, a decrease in kidney function itself had an increased risk of kidney failure, cardiovascular disease and death [18] [19] [20] [21] . Therefore, it is important to identify people at increased risk of adverse outcome because interventions in the early stages of CKD may slow or prevent an adverse outcome. Our results suggested that eGFR <75 mL/min/1.73m 2 and urine protein trace or more by dipstick were independently associated with ACM and CVM in the general population. Progressive increases in risks of mortality were noted according to a decrease in eGFR and the presence of proteinuria. Secondly, trace urine protein on dipstick was related to an increased risk for ACM and CVM compared to the same eGFR group with negative dipstick results. Finally, the risks of CVM were greater than ACM according to a decrease in eGFR and the presence of proteinuria. Similar findings have recently been reported [9-12, 20, 21 ]. However, the eGFR level at which the risk for ACM and CVM started to increase was 60-75 mL/min/1.73m 2 in our study. In addition, we did not find a U-shape association with higher risk of mortality at eGFR >105 mL/min/ 1.73m 2 in all participants [9] . In our analysis, only men showed higher HRs at eGFR >105 mL/min/1.73m 2 compared to the reference group; however, the difference was not statistically significant.
This result could be explained by several reasons. Firstly, we used standardized serum creatinine measured by the same kind of machine in all participants. The bias at high eGFR levels appears greater among reports in which the serum creatinine was not calibrated [22] . In our data, the risks for ACM were not significant according to eGFR before the calibration of serum creatinine in multivariate analysis [HR 1.02 (95% CI 0.49-2.12); 0.76 (0.54-1.06); 0.76 (0.54-1.06); 1.26 (0.83-1.90), for eGFR Group 1, 3, 4 and 5, respectively]. Although the bias between measured GFR and eGFR was greater when eGFR >60 mL/min/ 1.73m 2 , even after the IDMS calibration [13] , the accuracy of eGFR was improved by using the IDMS calibration, especially in the CKD Stages 1-3 [23] .
Secondly, the demographic characteristics of study population were different from those of other studies. Our population was considered representative of the healthy general population because they visited voluntarily to check-up their health status. The overall low mortality rate and comorbidities also reflected their good health status. Serum creatinine is underestimated in populations with lower muscle mass or decreased protein intake, especially in elderly and chronically ill people [24] . Our study may have excluded those with very poor conditions or acute events. Additionally, the population was racially homogenous. The distribution of cause of death in Korea is quite different from other countries [25] . The leading cause of death in the Korean general population is malignancy. In 2009, 28.6% of the total number of deaths in the general Korean population was due to cancer and 22.0% was due to cardiovascular death [16] . In our study population, there was a higher rate of mortality due to malignancy than when compared to the general Korean population. This might be explained by the characteristics of our study population where there is a low prevalence of cardiovascular disease and a lower average age. The overall prevalence of HTN and diabetes were 21.5 and 6.8% in our study, respectively. According to data from the Korean National Health and Nutrition Examination Survey, the overall prevalence of HTN and diabetes in Korea were 26.1 and 10.5% in 2007 [26] . Secondly, in the general Korean population, the number of deaths in those >80 years was 32.1% compared to 8.5% in our study population [16] . The average age at death in our study population was 65.1 AE 11.3 years. In those aged 60-69 years within the general Korean population, 43.0% of deaths was due to malignancy and 19.3% was due to CVM. These figures are similar to our study population [16] .
Pathological abnormalities were observed in early stages of CKD. In patients with CKD Stages 1-2, an inverse relationship with eGFR was observed for parathyroid hormone and fibroblast growth factor 23 [27] , which were associated with phosphate and vitamin D metabolism, vascular dysfunction and coronary artery disease [28, 29] . Furthermore, patients with eGFR 60-89 mL/min/1.73m 2 already have cardiovascular changes, such as reduced aortic distensibility and increases in arterial, ventricular systolic and diastolic stiffness [30] . Accordingly, our study showed that individuals with mild decrease in eGFR were at increased risk for adverse outcomes. The risk of adverse outcome was not confined to patients with eGFR <60 mL/ min/1.73m 2 . Therefore, interventions for cardiovascular risk factors are important in individuals with mild decrease in renal function.
There are several limitations in our study. Firstly, selection bias may have existed because our study population had an interest about their health status and were able to pay for their health examination at a tertiary hospital. Secondly, we used single measurements for eGFR and proteinuria and had no ACR data. However, urine analysis is one of the most common tests in clinical settings, the interpretation of urine analysis is important. Thirdly, we did not analyze the risks in the later stages of CKD or heavy proteinuria due to the few participants with later stages of CKD or heavy proteinuria. Finally, our participants were racially and geographically homogenous and had distinct features compared to other studies. Therefore, the results of this study may be limited to racial groups and geographical areas.
In conclusion, eGFR <75 mL/min/1.73m 2 and urine dipstick trace or more are independent risk factors of ACM and CVM in the Korean general population with uniform calibration of serum creatinine. These study results may provide additional prognostic information among the general population and suggests that the risks of adverse outcomes are greater in the population with mild renal impairment or mild proteinuria.
